Merck Digital Sciences Studio

mds.studio

MDSS invests in and supports early-stage startups developing digitally enabled technologies for drug discovery, pre-clinical, and clinical development. The firm connects innovators with industry leaders to accelerate innovation in digital biopharma.

Check Size

$100K - $100K

Stages

Pre Seed, Seed

Focus Areas

Ai Ml, Biotech, Healthtech

Is Merck Digital Sciences Studio right for your startup?

Upload your pitch deck and get an AI-powered match score in minutes. See exactly how well you fit their investment criteria.

See If You're a Match

Investment Thesis

Merck Digital Sciences Studio operates as a corporate-backed accelerator focused on empowering early-stage startups developing digitally enabled technologies for the pharmaceutical sector. Their philosophy emphasizes collaboration between innovators, researchers, and industry leaders, leveraging Merck’s global resources and expertise alongside mentoring from experienced advisors to accelerate breakthroughs in health technology. The program takes a hands-on approach by providing direct access to Merck experts, personalized guidance, and structured support over a nine-month period.

What Sets Them Apart

Direct access to Merck experts and global network
Structured 9-month accelerator program with defined curriculum
Multi-regional approach with partnerships in US (The Venture Collective) and Canada (CQDM)
Personalized mentoring from Centech advisors alongside industry experts
$100,000 USD SAFE investment from Merck Global Health Innovation Fund
Emphasis on founder diversity as an 'investor advantage for building outperforming startups'
Long-term collaboration model beyond the program duration
Integration with Microsoft Founders Hub for startup resources